Fernández Moro Carlos, Bozóky Béla, Gerling Marco
Division of Pathology, Department of Laboratory Medicine (LabMed), Karolinska Institute, Stockholm, Sweden.
Department of Clinical Pathology/Cytology, Karolinska University Hospital, Stockholm, Sweden.
BMJ Open Gastroenterol. 2018 Jul 27;5(1):e000217. doi: 10.1136/bmjgast-2018-000217. eCollection 2018.
Colorectal cancer liver metastases (CRLM) grow in distinct histological patterns that have been associated with outcome after surgical resection. We conducted a systematic review to evaluate the frequency of different CRLM growth patterns and their impact on prognosis.
We searched Embase and MEDLINE databases from inception to 1 December 2017 to identify studies that reported CRLM growth pattern histopathology, their frequencies, and/or data related to outcome.
We included a total of 23 studies (2432 patients with CRLM) published between 1991 and 2017. There were variations in the terminology used to describe the growth patterns as well as in their histopathological definitions. A 'desmoplastic' pattern was most frequently considered, followed by 'pushing' and 'replacement' patterns. Data supported the presence of both intralesional and interlesional heterogeneity. There were no differences in growth pattern distribution stratified by chemotherapy. While heterogeneity of histopathology assessment precluded formal meta-analysis, the majority of articles found favourable outcomes for desmoplastic and unfavourable outcomes for replacement CRLM, independently of when the study was conducted.
The results suggest that CRLM growth patterns may have prognostic potential and that they may be considered for standardised routine histopathological reporting. Further understanding of the different growth patterns may provide important insights into the biological mechanisms that underlie metastatic growth in the liver.
结直肠癌肝转移(CRLM)以不同的组织学模式生长,这些模式与手术切除后的预后相关。我们进行了一项系统评价,以评估不同CRLM生长模式的频率及其对预后的影响。
我们检索了从数据库建立至2017年12月1日的Embase和MEDLINE数据库,以识别报告CRLM生长模式组织病理学、其频率和/或与预后相关数据的研究。
我们纳入了1991年至2017年间发表的共23项研究(2432例CRLM患者)。用于描述生长模式的术语及其组织病理学定义存在差异。最常考虑的是“促结缔组织增生性”模式,其次是“推挤性”和“取代性”模式。数据支持瘤内和瘤间异质性的存在。按化疗分层的生长模式分布没有差异。虽然组织病理学评估的异质性妨碍了正式的荟萃分析,但大多数文章发现促结缔组织增生性CRLM预后良好,取代性CRLM预后不良,与研究进行的时间无关。
结果表明,CRLM生长模式可能具有预后潜力,可考虑将其用于标准化的常规组织病理学报告。对不同生长模式的进一步了解可能为肝转移生长的生物学机制提供重要见解。